DxNA, a molecular diagnostics company headquartered in St. George, Utah, announced today that the DxNA GeneSTAT PCR system has successfully completed evaluation studies under the direction of a California laboratory supported by the Joint FAO/IAEA Programme in Food and Agriculture.
DxNA Chief Executive Officer Phillip Grimm acknowledged the importance of the collaboration with the FAO in the establishment of a portable and mobile diagnostic system that demonstrates high sensitivity and specificity characteristics, but is also affordable throughout the world.
"Our interaction with the Joint FAO/IAEA Programme to develop the GeneSTAT portable platform system has been instrumental in developing our technology," Grimm said. "Our original task was to develop a rapid, portable device to be made available to developing nations to combat avian influenza in animals and humans. We now look forward to taking this device into the field for use under harsh, real-world conditions. As part of our agreement with the Joint FAO/IAEA Programme, our next step in this regard is to work with animal health experts dealing with H5N1 in Southeast Asia. We will continue to work with the Joint FAO/IAEA Programme, with world governments and other worldwide health organizations to provide this mobile PCR system to rapidly and accurately detect diseases in humans, animals and plants through our expansion of our technology."